| Authors: |
Lin RC; Phage Australia, Westmead Health Precinct, Sydney, Australia; Westmead Hospital, Western Sydney Local Health District, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia; School of Biomedical Sciences, University of New South Wales, New South Wales, Australia; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-Traditional Antibacterial Therapy (ESGNTA); Phagistry Steering Committee. Electronic address: ruby.lin@sydney.edu.au., Suh GA; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-Traditional Antibacterial Therapy (ESGNTA); Phagistry Steering Committee; Department of Medicine, Division of Infectious Disease, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: suh.gina@mayo.edu. |
